Job Reference: GTXHPRT2020 (please included in application email subject line)
Opening Date – 10th January 2020
Closing Date – 10th February 2020
Gentronix is seeking an enthusiastic and highly motivated scientist to join our in vitro genetic toxicology team as an in vitro mammalian gene mutation Study Director. The team is growing due to planned services expansion and needs a committed and organised individual to help drive the expansion of the in vitro genetic toxicology service offering. The role will require good integration into the existing team and close working with the other Study Directors. For the successful applicant, the role presents opportunities to build-on and further develop their skills as a toxicologist within a CRO environment, with scope for further career progression within a growing and successful business.
The successful candidate will lead the implementation and service delivery of the in vitro OECD 476 mammalian gene mutation assay, to sit alongside the genetic toxicology service portfolio of OECD 471, 474, 487 & 490 studies at Gentronix. The role will require direction of both non-GLP and GLP compliant studies, working alongside other Study Directors and Senior Management in the business. The successful candidate will be part of a growing team with a key role in supporting the company’s ambition to become the leading provider of specialist predictive toxicology products and services, expanding the company’s service offering within global chemical industry sectors.
- To lead the development and implementation of in vitro mammalian gene mutation studies (OECD 476) studies at Gentronix, in order to deliver contract research services operated in compliance with the principles of GLP.
- To function independently as a Study Director (or work towards such responsibilities) in compliance with the principles of GLP, acting independently as a single point of contact for the planning, execution, management and reporting of preclinical studies, which may include multi-site studies. Liaising with clients and sponsors, to deliver high quality science and expertise.
- Provide scientific leadership and development to laboratory and technical team, and support to other genetic toxicology service areas, where needed.
- To maintain an awareness of current scientific developments within genetic toxicology assessments that may impact the conduct and interpretation of all studies within the Study Director portfolio in order to maintain standards of scientific excellence
The successful applicant will have a higher degree (PhD etc.) with a clear toxicology focus or extensive employment experience of at least 5 years within genetic toxicology. Candidates with prior experience as a Study Director / Manager performing in vitro genetic toxicology assays and practical experience of the GLP principles are highly desirable. Applicants who currently lack Study Director experience but have clear knowledge of gene mutation assays and can demonstrate a desire and capability to work towards becoming a Study Director are equally encouraged to apply.
The successful applicant will need to demonstrate an understanding of the principles of genetic toxicology, and enthusiasm for the application of these in both a screening and regulatory setting. Knowledge of the conduct of OECD 476 studies is highly desirable, though candidates who have experience of other in vitro OECD guideline genetic toxicology studies are encouraged to apply.
The successful applicant will be a good communicator, a strong team member and have excellent attention to detail.
The successful applicant will be IT literate and proficient in the use of Microsoft Office applications, especially Word, Excel and Powerpoint.
Salary commensurate with the role and level of experience and further details available upon request from Matt Tate, Managing Director (firstname.lastname@example.org).
Applications consisting of a cover letter demonstrating the candidates relevant experience and why they are suitable for the role, along with a CV should be sent to email@example.com with the job reference number (GTXHPRT2020) included in the email subject. Please note, an email filter will be used to capture applications and those not including the job reference number may not be considered for shortlist and interview.
Closing Date for applications is 10th February 2020, where successful shortlisted applicants will then be invited for interview.